{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T07:59:30Z","timestamp":1792828770996,"version":"4.5.0"},"reference-count":24,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2015,4,2]],"date-time":"2015-04-02T00:00:00Z","timestamp":1427932800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur J Nucl Med Mol Imaging"],"published-print":{"date-parts":[[2015,7]]},"DOI":"10.1007\/s00259-015-3037-2","type":"journal-article","created":{"date-parts":[[2015,4,3]],"date-time":"2015-04-03T06:21:01Z","timestamp":1428042061000},"page":"1268-1275","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":42,"title":["Preoperative risk stratification using metabolic parameters of 18F-FDG PET\/CT in patients with endometrial cancer"],"prefix":"10.1007","volume":"42","author":[{"given":"Kazuhiro","family":"Kitajima","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuko","family":"Suenaga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshiko","family":"Ueno","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tetsuo","family":"Maeda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasuhiko","family":"Ebina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hideto","family":"Yamada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takashi","family":"Okunaga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazuhiro","family":"Kubo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keitarou","family":"Sofue","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomonori","family":"Kanda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yukihisa","family":"Tamaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazuro","family":"Sugimura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2015,4,2]]},"reference":[{"key":"3037_CR1","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1016\/S0140-6736(05)67063-8","volume":"366","author":"F Amant","year":"2005","unstructured":"Amant F, Moerman P, Neven P, Timmerman D, Van Limbergen E, Vergote I. Endometrial cancer. Lancet. 2005;366:491\u2013505.","journal-title":"Lancet"},{"key":"3037_CR2","doi-asserted-by":"crossref","first-page":"97","DOI":"10.4065\/83.1.97","volume":"83","author":"JN Bakkum-Gamez","year":"2008","unstructured":"Bakkum-Gamez JN, Gonzalez-Bosquet J, Laack NN, Mariani A, Dowdy SC. Current issues in the management of endometrial cancer. Mayo Clin Proc. 2008;83:97\u2013112.","journal-title":"Mayo Clin Proc"},{"key":"3037_CR3","doi-asserted-by":"crossref","first-page":"1352","DOI":"10.1016\/S0140-6736(12)60442-5","volume":"379","author":"JD Wright","year":"2012","unstructured":"Wright JD, Barrena Medel NI, Sehouli J, Fujiwara K, Herzog TJ. Contemporary management of endometrial cancer. Lancet. 2012;379:1352\u201360.","journal-title":"Lancet"},{"key":"3037_CR4","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1097\/00006231-200606000-00002","volume":"27","author":"T Torizuka","year":"2006","unstructured":"Torizuka T, Nakamura F, Takekuma M, Kanno T, Ogusu T, Yoshikawa E, et al. FDG PET for the assessment of myometrial infiltration in clinical stage I uterine corpus cancer. Nucl Med Commun. 2006;27:481\u20137.","journal-title":"Nucl Med Commun"},{"key":"3037_CR5","doi-asserted-by":"crossref","first-page":"1598","DOI":"10.2967\/jnumed.108.060145","volume":"50","author":"T Tsujikawa","year":"2009","unstructured":"Tsujikawa T, Yoshida Y, Kudo T, Kiyono Y, Kurokawa T, Kobayashi M, et al. Functional images reflect aggressiveness of endometrial carcinoma: estrogen receptor expression combined with 18F-FDG PET. J Nucl Med. 2009;50:1598\u2013604.","journal-title":"J Nucl Med"},{"key":"3037_CR6","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1111\/IGC.0b013e3181c3a288","volume":"20","author":"K Nakamura","year":"2010","unstructured":"Nakamura K, Kodama J, Okumura Y, Hongo A, Kanazawa S, Hiramatsu Y. The SUVmax of 18F-FDG PET correlates with histological grade in endometrial cancer. Int J Gynecol Cancer. 2010;20:110\u20135.","journal-title":"Int J Gynecol Cancer"},{"key":"3037_CR7","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/j.ygyno.2011.06.026","volume":"123","author":"K Nakamura","year":"2011","unstructured":"Nakamura K, Hongo A, Kodama J, Hiramatsu Y. The measurement of SUVmax of the primary tumor is predictive of prognosis for patients with endometrial cancer. Gynecol Oncol. 2011;123:82\u20137.","journal-title":"Gynecol Oncol"},{"key":"3037_CR8","doi-asserted-by":"crossref","first-page":"204","DOI":"10.3413\/nukmed-0375-10-12","volume":"50","author":"HJ Lee","year":"2011","unstructured":"Lee HJ, Ahn BC, Hong CM, Song BI, Kim HW, Kang S, et al. Preoperative risk stratification using 18F-FDG PET\/CT in women with endometrial cancer. Nuklearmedizin. 2011;50:204\u201313.","journal-title":"Nuklearmedizin"},{"key":"3037_CR9","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1007\/s00259-011-2057-9","volume":"39","author":"K Kitajima","year":"2012","unstructured":"Kitajima K, Kita M, Suzuki K, Senda M, Nakamoto Y, Sugimura K. Prognostic significance of SUVmax (maximum standardized uptake value) measured by [18F]FDG PET\/CT in endometrial cancer. Eur J Nucl Med Mol Imaging. 2012;39:840\u20135.","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"3037_CR10","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1016\/j.ygyno.2013.01.019","volume":"129","author":"SL Antonsen","year":"2013","unstructured":"Antonsen SL, Loft A, Fisker R, Nielsen AL, Andersen ES, H\u00f8gdall E, et al. SUVmax of 18FDG PET\/CT as a predictor of high-risk endometrial cancer patients. Gynecol Oncol. 2013;129:298\u2013303.","journal-title":"Gynecol Oncol"},{"key":"3037_CR11","doi-asserted-by":"crossref","first-page":"234813","DOI":"10.1155\/2014\/234813","volume":"2014","author":"M Walentowicz-Sadlecka","year":"2014","unstructured":"Walentowicz-Sadlecka M, Malkowski B, Walentowicz P, Sadlecki P, Marszalek A, Pietrzak T, et al. The preoperative maximum standardized uptake value measured by 18F-FDG PET\/CT as an independent prognostic factor of overall survival in endometrial cancer patients. Biomed Res Int. 2014;2014:234813.","journal-title":"Biomed Res Int"},{"key":"3037_CR12","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1016\/j.ygyno.2014.01.039","volume":"132","author":"H Ghooshkhanei","year":"2014","unstructured":"Ghooshkhanei H, Treglia G, Sabouri G, Davoodi R, Sadeghi R. Risk stratification and prognosis determination using 18F-FDG PET imaging in endometrial cancer patients: a systematic review and meta-analysis. Gynecol Oncol. 2014;132:669\u201376.","journal-title":"Gynecol Oncol"},{"key":"3037_CR13","doi-asserted-by":"crossref","first-page":"884","DOI":"10.2967\/jnumed.113.133801","volume":"55","author":"K Pak","year":"2014","unstructured":"Pak K, Cheon GJ, Nam HY, Kim SJ, Kang KW, Chung JK, et al. Prognostic value of metabolic tumor volume and total lesion glycolysis in head and neck cancer: a systematic review and meta-analysis. J Nucl Med. 2014;55:884\u201390.","journal-title":"J Nucl Med"},{"key":"3037_CR14","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1016\/j.ygyno.2012.03.021","volume":"125","author":"FY Liu","year":"2012","unstructured":"Liu FY, Chao A, Lai CH, Chou HH, Yen TC. Metabolic tumor volume by 18F-FDG PET\/CT is prognostic for stage IVB endometrial carcinoma. Gynecol Oncol. 2012;125:566\u201371.","journal-title":"Gynecol Oncol"},{"key":"3037_CR15","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1016\/j.ygyno.2013.06.021","volume":"130","author":"HH Chung","year":"2013","unstructured":"Chung HH, Lee I, Kim HS, Kim JW, Park NH, Song YS, et al. Prognostic value of preoperative metabolic tumor volume measured by 18F-FDG PET\/CT and MRI in patients with endometrial cancer. Gynecol Oncol. 2013;130:446\u201351.","journal-title":"Gynecol Oncol"},{"key":"3037_CR16","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1016\/j.ygyno.2013.05.011","volume":"130","author":"C Crivellaro","year":"2013","unstructured":"Crivellaro C, Signorelli M, Guerra L, De Ponti E, Pirovano C, Fruscio R, et al. Tailoring systematic lymphadenectomy in high-risk clinical early stage endometrial cancer: the role of 18F-FDG PET\/CT. Gynecol Oncol. 2013;130:306\u201311.","journal-title":"Gynecol Oncol"},{"key":"3037_CR17","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.1111\/1471-0528.12543","volume":"121","author":"SH Shim","year":"2014","unstructured":"Shim SH, Kim DY, Lee DY, Lee SW, Park JY, Lee JJ, et al. Metabolic tumour volume and total lesion glycolysis, measured using preoperative 18F-FDG PET\/CT, predict the recurrence of endometrial cancer. BJOG. 2014;121:1097\u2013106.","journal-title":"BJOG"},{"key":"3037_CR18","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1007\/s00259-014-2964-7","volume":"42","author":"S Sudo","year":"2015","unstructured":"Sudo S, Hattori N, Manabe O, Kato F, Mimura R, Magota K, et al. FDG PET\/CT diagnostic criteria may need adjustment based on MRI to estimate the presurgical risk of extrapelvic infiltration in patients with uterine endometrial cancer. Eur J Nucl Med Mol Imaging. 2015;42:676\u201384.","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"3037_CR19","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1016\/j.radonc.2010.07.003","volume":"96","author":"JA Lee","year":"2010","unstructured":"Lee JA. Segmentation of positron emission tomography images: some recommendations for target delineation in radiation oncology. Radiother Oncol. 2010;96:302\u20137.","journal-title":"Radiother Oncol"},{"key":"3037_CR20","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1007\/s00259-013-2357-3","volume":"40","author":"AM Maffione","year":"2013","unstructured":"Maffione AM, Ferretti A, Grassetto G, Bellan E, Capirci C, Chondrogiannis S, et al. Fifteen different 18F-FDG PET\/CT qualitative and quantitative parameters investigated as pathological response predictors of locally advanced rectal cancer treated by neoadjuvant chemoradiation therapy. Eur J Nucl Med Mol Imaging. 2013;40:853\u201364.","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"3037_CR21","doi-asserted-by":"crossref","first-page":"e405","DOI":"10.1016\/j.ejrad.2013.04.022","volume":"82","author":"SW Chen","year":"2013","unstructured":"Chen SW, Chen WT, Wu YC, Yen KY, Hsieh TC, Lin TY, et al. Which FDG\/PET parameters of the primary tumors in colon or sigmoid cancer provide the best correlation with the pathological findings? Eur J Radiol. 2013;82:e405\u201310.","journal-title":"Eur J Radiol"},{"key":"3037_CR22","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.ijgo.2009.02.012","volume":"105","author":"S Pecorelli","year":"2009","unstructured":"Pecorelli S. Revised FIGO staging for carcinoma of the vulva, cervix, and endometrium. Int J Gynaecol Obstet. 2009;105:103\u20134.","journal-title":"Int J Gynaecol Obstet"},{"key":"3037_CR23","doi-asserted-by":"crossref","first-page":"1707","DOI":"10.1093\/jnci\/djn397","volume":"100","author":"P Benedetti Panici","year":"2008","unstructured":"Benedetti Panici P, Basile S, Maneschi F, Alberto Lissoni A, Signorelli M, Scambia G, et al. Systematic pelvic lymphadenectomy vs. no lymphadenectomy in early-stage endometrial carcinoma: randomized clinical trial. J Natl Cancer Inst. 2008;100:1707\u201316.","journal-title":"J Natl Cancer Inst"},{"key":"3037_CR24","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/S0140-6736(09)60678-4","volume":"373","author":"H Kitchener","year":"2009","unstructured":"ASTEC study group, Kitchener H, Swart AM, Qian Q, Amos C, Parmar MK. Efficacy of systematic pelvic lymphadenectomy in endometrial cancer (MRC ASTEC trial): a randomised study. Lancet. 2009;373:125\u201336.","journal-title":"Lancet"}],"container-title":["European Journal of Nuclear Medicine and Molecular Imaging"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00259-015-3037-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00259-015-3037-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00259-015-3037-2","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,24]],"date-time":"2019-05-24T16:06:24Z","timestamp":1558713984000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00259-015-3037-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,4,2]]},"references-count":24,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2015,7]]}},"alternative-id":["3037"],"URL":"https:\/\/doi.org\/10.1007\/s00259-015-3037-2","relation":{},"ISSN":["1619-7070","1619-7089"],"issn-type":[{"value":"1619-7070","type":"print"},{"value":"1619-7089","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,4,2]]}}}